← Back to Clinical Trials
Recruiting NCT07761364

NCT07761364 Physiological Changes in Adult Intensive Care Patients Following Contact With Their Primary Caregiver

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07761364
Status Recruiting
Phase
Sponsor Universidad Autonoma del Estado de Mexico
Condition Critical Illness
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-08-01
Primary Completion 2026-08-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 59 Years
Study Type INTERVENTIONAL
Interventions
Standardized therapeutic physical contact

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-08-01 with a primary completion date of 2026-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Patients admitted to intensive care units are exposed to multiple environmental and clinical factors that may affect their physiological responses. This randomized controlled trial aims to evaluate the effect of physical contact with the primary caregiver on physiological parameters in adult patients hospitalized in an intensive care unit.

Eligibility Criteria

Inclusion Criteria Patient Criteria: * Adults aged 18 years or older. * Admission to the intensive care unit (ICU) for 24 to 48 hours. * Richmond Agitation-Sedation Scale (RASS) score between -3 and -1 or between 0 and +3. * Glasgow Coma Scale score greater than 13. Primary Caregiver Criteria: * Identified as the patient's primary caregiver. * Willing and able to participate in the study. * Provides written informed consent prior to study participation. Exclusion Criteria Patient Criteria: * Diagnosis of a neurological disorder (e.g., cerebrovascular disease or stroke). * Multiple organ dysfunction syndrome (MODS). * Unstable or difficult-to-control cardiac arrhythmias. * Fever (body temperature ≥ 37.5°C) at the time of assessment. * Hypertension (blood pressure ≥ 130/80 mmHg) at the time of assessment. Primary Caregiver Criteria: \- Unable to be present to perform the intervention according to the study protocol.

Contact & Investigator

Central Contact

Isabel Álvarez-Solorza, Dr.

✉ ialvarezs@uaemex.mx

📞 +52 1 7222231161

Principal Investigator

Isabel Álvarez-Solorza, RN, PhD

PRINCIPAL INVESTIGATOR

Universidad Autonoma del Estado de Mexico

Frequently Asked Questions

Who can join the NCT07761364 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 59 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07761364 currently recruiting?

Yes, NCT07761364 is actively recruiting participants. Contact the research team at ialvarezs@uaemex.mx for enrollment information.

Where is the NCT07761364 trial being conducted?

This trial is being conducted at Mexico City, Mexico.

Who is sponsoring the NCT07761364 clinical trial?

NCT07761364 is sponsored by Universidad Autonoma del Estado de Mexico. The principal investigator is Isabel Álvarez-Solorza, RN, PhD at Universidad Autonoma del Estado de Mexico. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology